Showing results (81-90 of 1,227) with videos related to

Sort By:
Pageof 123
Cancer Treatment and Research Communications|September 26, 2022
EGFR-mutation testing and TKI treatment patterns in locally advanced and metastatic NSCLC in Norway - A nationwide retrospective cohort studyÅslaug Helland, Klaus Kaae Andersen, Tor Åge Myklebust, et al.
Cancer Treatment and Research Communications|January 14, 2021
Oncotype DX and Prosigna in breast cancer patients: A comparison studyDina A Abdelhakam, Helena Hanna, Aziza Nassar
Cancer Treatment and Research Communications|January 17, 2021
Role of nano-sensitizers in radiation therapy of metastatic tumorsAjinkya Madhukar Thanekar, Sri Amruthaa Sankaranarayanan, Aravind Kumar Rengan
Cancer Treatment and Research Communications|March 23, 2021
Ponatinib-associated panniculitis: Case report and review of the literatureDaniel Antwi-Amoabeng, Joban Ghuman, Jasmine Ghuman, et al.
Cancer Treatment and Research Communications|March 12, 2021
High gene expression of estrogen and progesterone receptors is associated with decreased t cell infiltration in patients with NSCLCMichael S Oh, Jonathan F Anker, Young Kwang Chae
Cancer Treatment and Research Communications|January 31, 2021
Body composition and metastatic prostate cancer survivorshipAdriana M Coletta, Nicolas Sayegh, Neeraj Agarwal
Cancer Treatment and Research Communications|February 2, 2021
The role of telomerase and viruses interaction in cancer development, and telomerase-dependent therapeutic approachesAli Salimi-Jeda, Fariba Badrzadeh, Maryam Esghaei, et al.
Cancer Treatment and Research Communications|December 19, 2021
A systematic update to circulating extracellular vesicles proteome; transcriptome and small RNA-ome as glioma diagnostic, prognostic and treatment-response biomarkersMehdi Nikoobakht, Parisa Shamshiripour, Mohadeseh Shahin, et al.
Cancer Treatment and Research Communications|January 9, 2022
Presenting features and overall survival of chondrosarcoma of the pelvisJeffrey Mark Brown, Kyla Rakoczy, Jacqueline Hart, et al.
Cancer Treatment and Research Communications|January 16, 2022
Survival of clinical stage III NSCLC according to therapeutic strategy: Relevance of the tumor board decision in the era of immunotherapyJustin Benet, Anne-Claire Toffart, Pierre-Yves Brichon, et al.
Pageof 123